Jin-Yong Park1, Su-Kyoung Lee1, Jeong-Yeon Kim1, Kang-Hoon Je1, Dawid Schellingerhout1, Dong-Eog Kim2. 1. From the Molecular Imaging and Neurovascular Research (MINER) Laboratory, Department of Neurology, Dongguk University Ilsan Hospital, Goyang, Korea (J.-Y.P., S.-K.L., J.-Y.K., K.-H.J., D.-E.K.); and Departments of Radiology and Experimental Diagnostic Imaging, University of Texas MD Anderson Cancer Center, Houston (D.S.). 2. From the Molecular Imaging and Neurovascular Research (MINER) Laboratory, Department of Neurology, Dongguk University Ilsan Hospital, Goyang, Korea (J.-Y.P., S.-K.L., J.-Y.K., K.-H.J., D.-E.K.); and Departments of Radiology and Experimental Diagnostic Imaging, University of Texas MD Anderson Cancer Center, Houston (D.S.). kdongeog@duih.org.
Abstract
BACKGROUND AND PURPOSE: Micro-computed tomography (mCT) offers high-resolution images, but it suffers from low contrast sensitivity and poor soft tissue contrast. We introduce a new mCT imaging technique with improved sensitivity for the dynamic spatial and temporal characterization of poststroke blood-brain barrier (BBB) dysfunction in small animals in vivo. METHODS: Transient middle cerebral artery occlusion was induced for 1 hour in 10- to 12-week-old C57BL/6 mice (n=35). At 4, 24, and 48 hours after ischemic stroke, serial in vivo mCT imaging was performed 5 minutes after intravenous infusion (n=3) or intracarotid infusion of iopromide (240 μL) for 5 minutes (n=32). After intravenous injection of 2% Evans blue, we performed ex vivo near-infrared fluorescent imaging of parenchymal Evans blue leakage, visual assessment of poststroke parenchymal hematoma, triphenyltetrazolium chloride staining of the brain tissue, and quantitative mapping of stroke-related brain lesions. RESULTS: Infarct-related BBB dysfunction could be demonstrated with intra-arterial but not with intravenous infusion of iopromide. Iopromide leakage across the dysfunctional BBB showed a monophasic (not biphasic) course for 48 hours after ischemic insult in both the parenchymal hematoma (n=5) and the non-parenchymal hematoma (n=24) groups, with relatively severe leakiness and greater hemispheric midline shift in animals with hemorrhage. Parenchymal staining on in vivo mCT overlapped with ex vivo fluorescent staining because of Evans blue. Multivariable analyses showed that midline shift and the amount of iopromide leakage at each of the 3 time points predicted the final infarct size at 48 hours. CONCLUSIONS: The new mCT BBB imaging technique, based on the intra-arterial infusion of clinically available iopromide, allows serial quantitative visualization of poststroke BBB dysfunction in mice, with high resolution and in a sensitive manner.
BACKGROUND AND PURPOSE: Micro-computed tomography (mCT) offers high-resolution images, but it suffers from low contrast sensitivity and poor soft tissue contrast. We introduce a new mCT imaging technique with improved sensitivity for the dynamic spatial and temporal characterization of poststroke blood-brain barrier (BBB) dysfunction in small animals in vivo. METHODS: Transient middle cerebral artery occlusion was induced for 1 hour in 10- to 12-week-old C57BL/6 mice (n=35). At 4, 24, and 48 hours after ischemic stroke, serial in vivo mCT imaging was performed 5 minutes after intravenous infusion (n=3) or intracarotid infusion of iopromide (240 μL) for 5 minutes (n=32). After intravenous injection of 2% Evans blue, we performed ex vivo near-infrared fluorescent imaging of parenchymal Evans blue leakage, visual assessment of poststroke parenchymal hematoma, triphenyltetrazolium chloride staining of the brain tissue, and quantitative mapping of stroke-related brain lesions. RESULTS:Infarct-related BBB dysfunction could be demonstrated with intra-arterial but not with intravenous infusion of iopromide. Iopromide leakage across the dysfunctional BBB showed a monophasic (not biphasic) course for 48 hours after ischemic insult in both the parenchymal hematoma (n=5) and the non-parenchymal hematoma (n=24) groups, with relatively severe leakiness and greater hemispheric midline shift in animals with hemorrhage. Parenchymal staining on in vivo mCT overlapped with ex vivo fluorescent staining because of Evans blue. Multivariable analyses showed that midline shift and the amount of iopromide leakage at each of the 3 time points predicted the final infarct size at 48 hours. CONCLUSIONS: The new mCT BBB imaging technique, based on the intra-arterial infusion of clinically available iopromide, allows serial quantitative visualization of poststroke BBB dysfunction in mice, with high resolution and in a sensitive manner.
Authors: J Ciaran Hutchinson; Susan C Shelmerdine; Ian C Simcock; Neil J Sebire; Owen J Arthurs Journal: Br J Radiol Date: 2017-05-04 Impact factor: 3.039
Authors: Raquel Pinto; Jan Matula; Andrea Lobo; Maria Gomez-Lazaro; Mafalda Sousa; Tomas Zikmund; Jozef Kaiser; João R Gomes Journal: Sci Rep Date: 2022-10-19 Impact factor: 4.996
Authors: Romuald Girard; Hussein A Zeineddine; Courtney Orsbon; Huan Tan; Thomas Moore; Nick Hobson; Robert Shenkar; Rhonda Lightle; Changbin Shi; Maged D Fam; Ying Cao; Le Shen; April I Neander; Autumn Rorrer; Carol Gallione; Alan T Tang; Mark L Kahn; Douglas A Marchuk; Zhe-Xi Luo; Issam A Awad Journal: J Neurosci Methods Date: 2016-06-23 Impact factor: 2.390
Authors: Liqiang Ren; Muhammad U Ghani; Di Wu; Bin Zheng; Yong Chen; Kai Yang; Xizeng Wu; Hong Liu Journal: J Appl Clin Med Phys Date: 2016-01-08 Impact factor: 2.102
Authors: Jana Mrzílková; Matěj Patzelt; Pasquale Gallina; Zdeněk Wurst; Martin Šeremeta; Jan Dudák; František Krejčí; Jan Žemlička; Vladimír Musil; Jakub Karch; Jozef Rosina; Petr Zach Journal: Biomed Res Int Date: 2019-07-14 Impact factor: 3.411